2015 Publications

WholeMycobacteriaCellVaccinesforTuberculosisSummaryGroup; (including White, RG; ); (2015) Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

 

Ahmeti, A; Preza, I; Simaku, A; Nelaj, E; Clark, AD; Felix Garcia, AG; Lara, C; Hoestlandt, C; Blau, J; Bino, S; (2015) Cost-effectiveness of rotavirus vaccination in Albania. Vaccine, 33 Suppl 1. A201-8. ISSN 0264-410X DOI:10.1016/j.vaccine.2014.12.075

 

Anstey, NM; Auburn, S; Baird, JK; Battle, KE; Bobogare, A; Chancellor, A; Chasombat, S; Cheng, Q; Domingo, GJ; Drakeley, CJ; +37 more… (2015) Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group. Malaria Journal, 14. p. 11. ISSN 1475-2875 DOI: 10.1186/s12936-015-0958-y

 

Baguelin, M; Camacho, A; Flasche, S; Edmunds, WJ; (2015) Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study. BMC Med, 13 (1). p. 236. ISSN 1741-7015 DOI: 10.1186/s12916-015-0452-y

 

Boelsen, LK; Dunne, EM; Lamb, KE; Bright, K; Cheung, YB; Tikoduadua, L; Russell, FM; Mulholland, EK; Licciardi, PV;Satzke, C; (2015) Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children following a reduced dose pneumococcal conjugate vaccine primary series in infancy. Vaccine, 33 (42). pp. 5708-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.07.059

 

Bojang, A; Jafali, J; Egere, UE; Hill, PC; Antonio, M; Jeffries, D; Greenwood, BM; Roca, A; (2015) Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine Trial. PLoS One, 10 (7). e0129649. ISSN 1932-6203 DOI: 10.1371/journal.pone.0129649

 

 

 

Bottomley, C; Bojang, A; Smith, PG; Darboe, O; Antonio, M; Foster-Nyarko, E; Kampmann, B; Greenwood, B;D’Alessandro, U; Roca, A; (2015) The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study. Emerg Themes Epidemiol, 12 (1). p. 1. ISSN 1742-7622 DOI: 10.1186/s12982-014-0022-3

 

Brousseau, N; Green, HK; Andrews, N; Pryse, R; Baguelin, M; Sunderland, A; Ellis, J; Pebody, R; (2015) Impact of influenza vaccination on respiratory illness rates in children attending private boarding schools in England, 2013-2014: a cohort study. Epidemiology and infection, 143 (16). pp. 3405-3415. ISSN 0950-2688 DOI: 10.1017/S0950268815000667

 

Burton, DC; Bigogo, GM; Audi, AO; Williamson, J; Munge, K; Wafula, J; Ouma, D; Khagayi, S; Mugoya, I; Mburu, J; +16 more… (2015) Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya. PLoS One, 10 (10). e0141896. ISSN 1932-6203 DOI:10.1371/journal.pone.0141896

 

Camacho, A; Eggo, RM; Funk, S; Watson, CH; Kucharski, AJ; Edmunds, WJ; (2015) Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach. BMJ Open, 5 (12). e009346. ISSN 2044-6055 DOI: 10.1136/bmjopen-2015-009346

 

Diop, A; Atherly, D; Faye, A; Lamine Sall, F; Clark, AD; Nadiel, L; Yade, B; Ndiaye, M; Fafa Cissé, M; Ba, M; (2015)Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis. Vaccine, 33 Suppl 1. A119-25. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.065

 

Feazel, LM; Santorico, SA; Robertson, CE; Bashraheil, M; Scott, JA; Frank, DN; Hammitt, LL; (2015) Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers. PLoS One, 10 (6). e0128064. ISSN 1932-6203 DOI:10.1371/journal.pone.0128064

 

Flasche, S; Le Polain de Waroux, O; OBrien, KL; Edmunds, WJ; (2015) The Serotype Distribution among Healthy Carriers before Vaccination Is Essential for Predicting the Impact of Pneumococcal Conjugate Vaccine on Invasive Disease.PLoS computational biology, 11 (4). e1004173. ISSN 1553-734X DOI: 10.1371/journal.pcbi.1004173

 

Flasche, S; Van Hoek, AJ; Goldblatt, D; Edmunds, WJ; O’Brien, KL; Scott, JA; Miller, E; (2015) The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries. PLoS medicine, 12 (6). e1001839. ISSN 1549-1277 DOI: 10.1371/journal.pmed.1001839

 

GBD 2013 Risk Factors Collaborators; Forouzanfar, MH; Alexander, L; Anderson, HR; Bachman, VF; Biryukov, S; Brauer, M;Burnett, R; Casey, D; Coates, MM; +712 more… (2015) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386 (10010). pp. 2287-323. ISSN 0140-6736 DOI:10.1016/S0140-6736(15)00128-2

Gamougam, K; Daugla, DM; Toralta, J; Ngadoua, C; Fermon, F; Page, A.-, L; Djingarey, MH; Caugant, DA; Manigart, O;Trotter, CL; +2 more… (2015) Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013.Emerging infectious diseases, 21 (1). pp. 115-118. ISSN 1080-6040 DOI: 10.3201/eid2101.140256

 

Henao-Restrepo, AM; Longini, IM; Egger, M; Dean, NE; Edmunds, WJ; Camacho, A; Carroll, MW; Doumbia, M; Draguez, B; Duraffour, S; +18 more… (2015) Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet, 386 (9996). pp. 857-66. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)61117-5

 

Heymann, DL; Rodier, GR; Ryan, MJ; (2015) Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out. Lancet. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)60645-6

 

Jarrett, C; Wilson, R; O’Leary, M; Eckersberger, E; Larson, HJ; SAGE Working Group on Vaccine Hesitancy; , COLLABORATORS; Eskola, J; Liang, X; Chaudhuri, M; +14 more… (2015) Strategies for addressing vaccine hesitancy – A systematic review. Vaccine, 33 (34). pp. 4180-90. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.040

 

Jauregui, B; Garcia, AG; Bess Janusz, C; Blau, J; Munier, A; Atherly, D; Mvundura, M; Hajjeh, R; Lopman, B; Clark, AD; +4 more… (2015) Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group’s experience. Vaccine, 33 Suppl 1. A28-33. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.10.090

 

Jit, M; (2015) High-dose influenza vaccines make economic sense for older people. The Lancet infectious diseases, 15 (12). pp. 1372-1373. ISSN 1473-3099 DOI: 10.1016/s1473-3099(15)00272-8

 

Jit, M; Hutubessy, R; Png, ME; Sundaram, N; Audimulam, J; Salim, S; Yoong, J; (2015) The broader economic impact of vaccination: reviewing and appraising the strength of evidence. BMC Med, 13 (1). p. 209. ISSN 1741-7015 DOI:10.1186/s12916-015-0446-9

 

Jit, M; Huyen, DT; Friberg, I; Van Minh, H; Kiet, PH; Walker, N; Van Cuong, N; Duong, TN; Toda, K; Hutubessy, R; +2 more… (2015) Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization. Vaccine, 33 Suppl 1. A233-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.017

 

Jit, M; Laprise, JF; Choi, YH; Brisson, M; (2015) Fewer than three doses of HPV vaccine. The lancet oncology, 16 (9). e423-4. ISSN 1470-2045 DOI: 10.1016/S1470-2045(15)00229-6

 

Jit, M; Mibei, W; (2015) Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review.Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.06.084

 

Jones, S; Grignard, L; Nebie, I; Chilongola, J; Dodoo, D; Sauerwein, R; Theisen, M; Roeffen, W; Singh, SK; Singh, RK; +5 more… (2015) Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates. The Journal of infection, 71 (1). pp. 117-27. ISSN 0163-4453 DOI: 10.1016/j.jinf.2015.03.007

Kieninger, MP; Caballero, EG; Sosa, AA; Amarilla, CT; Jáuregui, B; Janusz, CB; Clark, AD; Castellanos, RM; (2015) Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay. Vaccine, 33 Suppl 1. A143-53. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.078

 

King, EM; Gilson, R; Beddows, S; Soldan, K; Panwar, K; Young, C; Prah, P; Jit, M; Edmunds, WJ; Sonnenberg, P; (2015)Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies. British journal of cancer. ISSN 0007-0920 DOI: 10.1038/bjc.2015.90

 

Komakhidze, T; Hoestlandt, C; Dolakidze, T; Shakhnazarova, M; Chlikadze, R; Kopaleishvili, N; Goginashvili, K;Kherkheulidze, M; Clark, AD; Blau, J; (2015) Cost-effectiveness of pneumococcal conjugate vaccination in Georgia.Vaccine, 33 Suppl 1. A219-26. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.070

 

La Vincente, SF; Mielnik, D; Jenkins, K; Bingwor, F; Volavola, L; Marshall, H; Druavesi, P; Russell, FM; Lokuge, K;Mulholland, EK; (2015) Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents. BMC Public Health, 15 (1). p. 1257. ISSN 1471-2458 DOI: 10.1186/s12889-015-2579-3

 

Larson, H; (2015) The world must accept that the HPV vaccine is safe. Nature, 528 (7580). p. 9. ISSN 0028-0836 DOI:10.1038/528009a Full text not available from this repository.

Larson, HJ; Jarrett, C; Schulz, WS; Chaudhuri, M; Zhou, Y; Dube, E; Schuster, M; MacDonald, NE; Wilson, R; SAGE Working Group on Vaccine Hesitancy; +18 more… (2015) Measuring vaccine hesitancy: The development of a survey tool.Vaccine, 33 (34). pp. 4165-75. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.037

 

Larson, HJ; Schulz, WS; Tucker, JD; Smith, DM; (2015) Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr, 7. ISSN 2157-3999 DOI: 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4

 

Le, P; Griffiths, UK; Anh, DD; Franzini, L; Chan, W; Swint, JM; (2015) Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.05.050

 

Le Polain De Waroux, O; Flasche, S; Prieto-Merino, D; Goldblatt, D; Edmunds, WJ; (2015) The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-Regression Model. The Pediatric infectious disease journal, 34 (8). pp. 858-64. ISSN 0891-3668 DOI: 10.1097/INF.0000000000000717

 

Longini, IM; Egger, M; Dean, NE; Edmunds, WJ; Henao-Restrepo, AM; Study Steering, G; (2015) Ebola vaccination Reply.Lancet, 386 (10012). p. 2480. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)00951-4

 

MenAfriCar consortium; , COLLABORATORS; Ali, O; Aseffa, A; Bedru, A; Lema, T; Moti, T; Tekletsion, Y; Worku, A; Xabher, HG; +67 more… (2015) The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine. The Journal of infectious diseases, 212 (8). pp. 1298-307. ISSN 0022-1899 DOI: 10.1093/infdis/jiv211

 

Metcalf, CJ; Andreasen, V; Bjørnstad, ON; Eames, K; Edmunds, WJ; Funk, S; Hollingsworth, TD; Lessler, J; Viboud, C;Grenfell, BT; (2015) Seven challenges in modeling vaccine preventable diseases. Epidemics, 10. pp. 11-5. ISSN 1755-4365 DOI: 10.1016/j.epidem.2014.08.004

 

Mezones-Holguin, E; Canelo-Aybar, C; Clark, AD; Janusz, CB; Jaúregui, B; Escobedo-Palza, S; Hernandez, AV; Vega-Porras, D; González, M; Fiestas, F; +3 more… (2015) Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine, 33 Suppl 1. A154-66. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.039

 

Minassian, C; Thomas, S; Smeeth, L; Douglas, I; Brauer, R; Langan, S; (2015) Herpes zoster, acute cardiovascular events and the role of zoster vaccination.

 

Minassian, C; Thomas, SL; Smeeth, L; Douglas, I; Brauer, R; Langan, SM; (2015) Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. PLoS medicine, 12 (12). e1001919. ISSN 1549-1277 DOI: 10.1371/journal.pmed.1001919

 

Moon, S; Sridhar, D; Pate, MA; Jha, AK; Clinton, C; Delaunay, S; Edwin, V; Fallah, M; Fidler, DP; Garrett, L; +12 more…(2015) Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet, 386 (10009). pp. 2204-21. ISSN 0140-6736 DOI:10.1016/S0140-6736(15)00946-0

 

Neafsey, DE; Juraska, M; Bedford, T; Benkeser, D; Valim, C; Griggs, A; Lievens, M; Abdulla, S; Adjei, S; Agbenyega, T; +53 more… (2015) Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. The New England journal of medicine, 373 (21). pp. 2025-37. ISSN 0028-4793 DOI: 10.1056/NEJMoa1505819

 

Nielsen, CM; White, MJ; Bottomley, C; Lusa, C; Rodríguez-Galán, A; Turner, SE; Goodier, MR; Riley, EM; (2015)Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals. Journal of immunology (Baltimore, Md . ISSN 0022-1767 DOI: 10.4049/jimmunol.1403080

 

Novaes, HM; de Soárez, PC; Silva, GA; Ayres, A; Itria, A; Rama, CH; Sartori, AM; Clark, AD; Resch, S; (2015) Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine, 33 Suppl 1. A135-42. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.031

 

O’Leary, M; Mulholland, K; (2015) Oral cholera vaccines in endemic countries. Lancet, 386 (10001). pp. 1321-2. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)60246-X

 

Odutola, A; Ota, MO; Ogundare, EO; Antonio, M; Owiafe, P; Worwui, A; Greenwood, B; Alderson, M; Traskine, M; Verlant, V; +2 more… (2015) Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: a phase II randomized study. Human vaccines & immunotherapeutics. ISSN 2164-5515 DOI:10.1080/21645515.2015.1111496

Pan, XF; Griffiths, UK; Pennington, M; Yu, H; Jit, M; (2015) Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making? Vaccine. ISSN 0264-410X DOI:10.1016/j.vaccine.2015.09.081

 

Peretti-Watel, P; Larson, HJ; Ward, JK; Schulz, WS; Verger, P; (2015) Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr, 7. ISSN 2157-3999 DOI:10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289

 

Prentice, S; Webb, EL; Dockrell, HM; Kaleebu, P; Elliott, AM; Cose, S; (2015) Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial. Trials, 16 (1). p. 149. ISSN 1745-6215 DOI: 10.1186/s13063-015-0682-5

 

RTS,S Clinical Trials Partnership; Tinto, H; D’Alessandro, U; Sorgho, H; Valea, I; Tahita, MC; Kabore, W; Kiemde, F;Lompo, P; Ouédraogo, S; +136 more… (2015) Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet, 386 (9988). pp. 31-45. ISSN 0140-6736 DOI: 10.1016/S0140-6736(15)60721-8

 

Roca, A; Bojang, A; Bottomley, C; Gladstone, RA; Adetifa, JU; Egere, U; Burr, S; Antonio, M; Bentley, S; Kampmann, B; +8 more… (2015) Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in the Gambia. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.11.012

 

Satzke, C; Dunne, EM; Porter, BD; Klugman, KP; Mulholland, EK; PneuCarriage project group; (2015) The PneuCarriage Project: A Multi-Centre Comparative Study to Identify the Best Serotyping Methods for Examining Pneumococcal Carriage in Vaccine Evaluation Studies. PLoS medicine, 12 (11). e1001903. ISSN 1549-1277 DOI: 10.1371/journal.pmed.1001903

 

Seifert, K; Juhls, C; Salguero, FJ; Croft, SL; (2015) Sequential chemo-immunotherapy of experimental visceral leishmaniasis using single low dose liposomal amphotericin B and a novel DNA vaccine candidate. Antimicrobial agents and chemotherapy, 59 (9). pp. 5819-23. ISSN 0066-4804 DOI: 10.1128/AAC.00273-15 Full text not available from this repository.

Sigei, C; Odaga, J; Mvundura, M; Madrid, Y; Clark, AD; Kenya ProVac Technical Working Group; Uganda ProVac Technical Working Group; (2015) Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine, 33 Suppl 1. A109-18. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.079

 

Smith, SG; Smits, K; Joosten, SA; van Meijgaarden, KE; Satti, I; Fletcher, HA; Caccamo, N; Dieli, F; Mascart, F; McShane, H; +3 more… (2015) Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines. PLoS One, 10 (9). e0138042. ISSN 1932-6203 DOI: 10.1371/journal.pone.0138042

 

Steffen, R; Behrens, RH; Hill, DR; Greenaway, C; Leder, K; (2015) Vaccine-Preventable Travel Health Risks: What Is the Evidence-What Are the Gaps? Journal of travel medicine, 22 (1). pp. 1-12. ISSN 1195-1982 DOI: 10.1111/jtm.12171

Thorrington, D; Jit, M; Eames, K; (2015) Targeted vaccination in healthy school children – Can primary school vaccination alone control influenza? Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.08.031

 

Toh, ZQ; Licciardi, PV; Fong, J; Garland, SM; Tabrizi, SN; Russell, FM; Mulholland, EK; (2015) Reduced dose human papillomavirus vaccination: An update of the current state-of-the-art. Vaccine, 33 (39). pp. 5042-50. ISSN 0264-410X DOI:10.1016/j.vaccine.2015.07.102

 

Torres-Rueda, S; Burchett, HE; Griffiths, UK; Ongolo-Zogo, P; Edengue, JM; Kitaw, Y; Molla, M; Gelmon, L; Onyango-Ouma, W; Konate, M; +1 more… (2015) New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems’ impacts. African health sciences, 15 (3). pp. 868-77. ISSN 1680-6905 DOI: 10.4314/ahs.v15i3.22

 

Ultsch, B; Damm, O; Beutels, P; Bilcke, J; Brüggenjürgen, B; Gerber-Grote, A; Greiner, W; Hanquet, G; Hutubessy, R; Jit, M;+10 more… (2015) Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. ISSN 1170-7690 DOI:10.1007/s40273-015-0335-2

 

Usuf, E; Bojang, A; Hill, PC; Bottomley, C; Greenwood, B; Roca, A; (2015) Nasopharyngeal colonization of Gambian infants by Staphylococcus aureus and Streptococcus pneumoniae before the introduction of pneumococcal conjugate vaccines. New Microbes New Infect, 10. pp. 13-8. ISSN 2052-2975 DOI: 10.1016/j.nmni.2015.12.002

 

Van-Dunem, JC; Rodrigues, LC; Alencar, LC; Militão-Albuquerque, MdeF; Ximenes, RA; (2015) Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children. BioMed research international, 2015. p. 275029. ISSN 2314-6133 DOI: 10.1155/2015/275029

 

Vučina, VV; Filipović, SK; Kožnjak, N; Stamenić, V; Clark, AD; Mounaud, B; Blau, J; Hoestlandt, C; Kaić, B; (2015) Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vaccine, 33 Suppl 1. A209-18. ISSN 0264-410X DOI:10.1016/j.vaccine.2014.12.043

 

WAMIN consortium authors include (in alphabetical order):; Ahouidi, AD; Amambua-Ngwa, A; Awandare, GA; Bei, AK;Conway, DJ; Diakite, M; Duraisingh, MT; Rayner, JC; Zenonos, ZA; (2015) Malaria Vaccine Development: Focusing Field Erythrocyte Invasion Studies on Phenotypic Diversity: The West African Merozoite Invasion Network (WAMIN). Trends in parasitology. ISSN 1471-4922 DOI: 10.1016/j.pt.2015.11.009

 

Walwyn, L; Janusz, CB; Clark, AD; Prieto, E; Waight, E; Largaespada, N; (2015) Cost-effectiveness of HPV vaccination in Belize. Vaccine, 33 Suppl 1. A174-81. ISSN 0264-410X DOI: 10.1016/j.vaccine.2014.12.042

 

Watson, CH; (2015) Evaluating typhoid vaccine effectiveness in travelers’ vaccination. Journal of travel medicine, 22 (2). pp. 76-7. ISSN 1195-1982 DOI: 10.1111/jtm.12185

 

Watson, CH; Edmunds, WJ; (2015) A review of typhoid fever transmission dynamic models and economic evaluations of vaccination. Vaccine, 33 Suppl 3. C42-54. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.04.013

 

Watson-Jones, D; Mugo, N; Lees, S; Mathai, M; Vusha, S; Ndirangu, G; Ross, DA; (2015) Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya. PLoS One, 10 (6). e0123701. ISSN 1932-6203 DOI:10.1371/journal.pone.0123701

 

White, MT; Verity, R; Griffin, JT; Asante, KP; Owusu-Agyei, S; Greenwood, B; Drakeley, C; Gesase, S; Lusingu, J;Ansong, D; +28 more… (2015) Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. The Lancet infectious diseases, 15 (12). pp. 1450-1458. ISSN 1473-3099 DOI: 10.1016/s1473-3099(15)00239-x

 

Wilson, RJ; Paterson, P; Jarrett, C; Larson, HJ; (2015) Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review. Vaccine, 33 (47). pp. 6420-9. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.08.046

 

de Francisco Shapovalova, N; Donadel, M; Jit, M; Hutubessy, R; (2015) A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. ISSN 0264-410X DOI: 10.1016/j.vaccine.2015.10.066

 

van der Putten, IM; Evers, SM; Deogaonkar, R; Jit, M; Hutubessy, RC; (2015) Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study. BMC Public Health, 15 (1). p. 356. ISSN 1471-2458 DOI: 10.1186/s12889-015-1638-0